Carmat SA
Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Carmat SA (CXT) - Total Assets
Latest total assets as of December 2024: €42.43 Million EUR
Based on the latest financial reports, Carmat SA (CXT) holds total assets worth €42.43 Million EUR as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Carmat SA - Total Assets Trend (2013–2024)
This chart illustrates how Carmat SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Carmat SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Carmat SA's total assets of €42.43 Million consist of 76.3% current assets and 23.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 11.1% |
| Accounts Receivable | €1.54 Million | 3.6% |
| Inventory | €19.81 Million | 46.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €73.00K | 0.2% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Carmat SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Carmat SA's current assets represent 76.3% of total assets in 2024, a decrease from 92.6% in 2013.
- Cash Position: Cash and equivalents constituted 11.1% of total assets in 2024, down from 76.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 46.7% of total assets.
Carmat SA Competitors by Total Assets
Key competitors of Carmat SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Carmat SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Carmat SA generates 0.16x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Carmat SA is currently not profitable relative to its asset base.
Carmat SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 2.07 | 6.66 |
| Quick Ratio | 0.66 | 0.90 | 6.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €13.28 Million | € 21.95 Million | € 50.19 Million |
Carmat SA - Advanced Valuation Insights
This section examines the relationship between Carmat SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1166.97 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -20.0% |
| Total Assets | €42.43 Million |
| Market Capitalization | $1.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Carmat SA's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Carmat SA's assets decreased by 20.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Carmat SA (2013–2024)
The table below shows the annual total assets of Carmat SA from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €42.43 Million | -20.05% |
| 2023-12-31 | €53.07 Million | -37.74% |
| 2022-12-31 | €85.24 Million | +23.39% |
| 2021-12-31 | €69.08 Million | +15.45% |
| 2020-12-31 | €59.84 Million | -7.48% |
| 2019-12-31 | €64.68 Million | +75.61% |
| 2018-12-31 | €36.83 Million | -47.27% |
| 2017-12-31 | €69.85 Million | +86.32% |
| 2016-12-31 | €37.49 Million | +333.42% |
| 2015-12-31 | €8.65 Million | -38.40% |
| 2014-12-31 | €14.04 Million | -36.13% |
| 2013-12-31 | €21.98 Million | -- |